MarketWatch headline: U.K. regulator is first to authorize Moderna’s bivalent COVID booster for 18-and-older population
Last Updated: Aug. 15, 2022 at 1:36 p.m. ET
The U.K. regulator has become the first to authorize Moderna’s bivalent COVID vaccine booster for use in adults aged 18 and older.
The Medicines and Healthcare products Regulatory Agency gave the nod to the booster, identified as mRNA-1273.214, which targets the original virus strain, as well as the omicron variant.
The decision was based on data from a Phase 2/3 trial that met all primary goals, including superior neutralizing antibody response against omicron (BA.1) when compared with a 50-milligram booster dose of mRNA-1273.
$MRNA daily chart
$MRNA weekly chart
$MRNA monthly chart